Status:

UNKNOWN

A Prediction Model of 28-day Mortality in Septic Shock

Lead Sponsor:

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions:

Septic Shock

Eligibility:

All Genders

18+ years

Brief Summary

This clinical study adopts the design of cohort research, selects the sepsis shock patients admitted to our hospital ICU as the research object, takes the 28-day mortality rate as the outcome index, c...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years of age, gender-neutral;
  • Diagnosed with sepsis shock;
  • ICU survives longer than 48 h;
  • The preservation of clinical data is complete;

Exclusion

  • \- Diagnosed with sepsis shock within 6 hours of emergency treatment; Combined with people with autoimmune diseases; 3. Organ transplantation or immunosuppressive treatment; 4. Severe heart, liver and kidney insufficiency; 5. Late stage of malignant tumor; 6. Maternity; 7. Referral or referral to another hospital;

Key Trial Info

Start Date :

December 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

530 Patients enrolled

Trial Details

Trial ID

NCT04915625

Start Date

December 1 2020

End Date

December 31 2022

Last Update

June 7 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hanzhou, Zhejiang, China, 310000